About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.53 (-1.24%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
PHAR price activity
Last Price
$9.530
Change (24hr)
-0.12 USD (-1.24%)
Volume
1.57K
Volume (4w avg)
-
Open
$9.65
Day Range
$9.44 - $9.77
Previous Close
$9.65
Last Trade
08 Oct, 4:11 pm GMT+0
Delayed
08 Oct, 4:11 pm GMT+0
PHAR price performance
Delayed
08 Oct, 4:11 pm GMT+0
PHAR Market Signals